These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 229802)

  • 61. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alterations in glycosphingolipid patterns in a line of African green monkey kidney cells infected with herpesvirus.
    Schroder EW; Merrick JM
    J Virol; 1979 Dec; 32(3):734-40. PubMed ID: 229262
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of disodium phosphonoacetate and iododeoxyuridine on the multiplication of African swine fever virus in vitro.
    Gil-Fernández C; Páez E; Vilas P; Gancedo AG
    Chemotherapy; 1979; 25(3):162-9. PubMed ID: 378573
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of cytomegalovirus late antigens by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential action of deoxynucleosides on mammalian cell cultures infected with herpes simplex virus types 1 and 2.
    Kelman AD; Capozza FE; Kibrick S
    J Infect Dis; 1975 Apr; 131(4):452-5. PubMed ID: 163871
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Electron microscopy of herpes simplex virus. 3. Effect of hydroxyurea.
    Nii S; Rosenkranz HS; Morgan C; Rose HM
    J Virol; 1968 Oct; 2(10):1163-71. PubMed ID: 4302019
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of inhibitory action of concanamycins against herpes simplex virus.
    Hayashi K; Kawauchi M; Nakai C; Sankawa U; Seto H; Hayashi T
    Antivir Chem Chemother; 2001 Jan; 12(1):51-9. PubMed ID: 11437322
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential effects of 5-methylmercapto-2'-deoxyuridine on the replication of herpes simplex virus type 1 in two cell systems.
    Hardi R; Hughes RG; Ho YK; Chadha KC; Bardos TJ
    Antimicrob Agents Chemother; 1976 Oct; 10(4):682-6. PubMed ID: 185952
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of delta-9-tetrahydrocannabinol on herpes simplex virus replication.
    Blevins RD; Dumic MP
    J Gen Virol; 1980 Aug; 49(2):427-31. PubMed ID: 6255077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
    Birch CJ; Tyssen DP; Tachedjian G; Doherty R; Hayes K; Mijch A; Lucas CR
    J Infect Dis; 1992 Jul; 166(1):108-12. PubMed ID: 1318909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dissociation of the inhibitory effects of 2-deoxy-D-glucose on Vero cell growth and the replication of herpes simplex virus.
    Spivack JG; Prusoff WH; Tritton TR
    Antimicrob Agents Chemother; 1982 Aug; 22(2):284-8. PubMed ID: 6100424
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rose bengal inhibits herpes simplex virus replication in vero and human corneal epithelial cells in vitro.
    Chodosh J; Banks MC; Stroop WG
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2520-7. PubMed ID: 1321799
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
    Campione-Piccardo J; Rawls WE
    Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
    Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
    J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1.
    Lerner AM; Bailey EJ
    J Infect Dis; 1974 Nov; 130(5):549-52. PubMed ID: 4371532
    [No Abstract]   [Full Text] [Related]  

  • 76. Adaptation of herpes simplex virus type 1 to supraoptimal temperature. II. Immunofluorescent and cytological study of virus-infected cells, adapted and non-adapted to 40 degrees C.
    Lesso J; Szántó J
    Acta Virol; 1974 Nov; 18(6):486-92. PubMed ID: 4156156
    [No Abstract]   [Full Text] [Related]  

  • 77. [Production of J-96 cell culture chronically infected with herpes simplex virus and study of some of its properties].
    Sovetova GP; Spynu KI; Amchenkova AM
    Vopr Virusol; 1976; (4):456-61. PubMed ID: 188253
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro.
    Naito T; Shiota H; Nitta K; Mimura Y
    Jpn J Ophthalmol; 1990; 34(1):15-21. PubMed ID: 2163462
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nuclear membrane changes in herpes simplex virus-infected BHK-21 cells as seen by freeze-fracture.
    Haines H; Baerwald RJ
    J Virol; 1976 Mar; 17(3):1038-42. PubMed ID: 176438
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structure-activity studies on phosphonoacetate.
    Mao JC; Otis ER; von Esch AM; Herrin TR; Fairgrieve JS; Shipkowitz NL; Duff RG
    Antimicrob Agents Chemother; 1985 Feb; 27(2):197-202. PubMed ID: 2984985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.